Clinical
New clinical trial registered for Semaglutide
Related compound: SemaglutideView source →
Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy (NCT07511543) registered on ClinicalTrials.gov. Phase: phase 2. Status: not yet recruiting.